<?xml version="1.0" encoding="UTF-8"?>
<ref id="B5-pharmaceutics-12-00138">
 <label>5.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ladel</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Arghavan</surname>
    <given-names>J.F.</given-names>
   </name>
   <name>
    <surname>Zadeh</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Filzwieser</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Walter</surname>
    <given-names>J.-C.</given-names>
   </name>
   <name>
    <surname>Schlossbauer</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Kinscherf</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Lischka</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Luksch</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Schindowski</surname>
    <given-names>K.</given-names>
   </name>
  </person-group>
  <article-title>Allogenic Fc domain-facilitated uptake of IgG in nasal lamina propria: Friend or foe for intranasal CNS delivery?</article-title>
  <source>Pharmaceutics</source>
  <year>2018</year>
  <volume>10</volume>
  <elocation-id>107</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics10030107</pub-id>
  <?supplied-pmid 30050027?>
  <pub-id pub-id-type="pmid">30050027</pub-id>
 </element-citation>
</ref>
